About
Metabolic Neuromodulation Therapy
Areas of Focus
Categories
Surgical DeviceMidwest
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
136
By Phase
NA: 4
By Status
COMPLETED: 3UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT04917393Lead Sponsor
Multi-Organ Denervation With the iRF System to RedUce Sympathetic Drive
NAUnknown
45 participants
Started: Sep 13, 2021 · Completed: Oct 1, 2023
NCT04740723Lead Sponsor
Evaluation of the Integrated Radio Frequency Denervation System for the Treatment of Hypertension
NACompleted
30 participants
Started: Feb 6, 2021 · Completed: Oct 13, 2022
NCT04285554Lead Sponsor
Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects
NACompleted
15 participants
Started: Jul 28, 2020 · Completed: Dec 19, 2022
NCT02278068Lead Sponsor
COMPLEMENT Study- A First in Human Study of Metabolic Neuromodulation Therapy
NACompleted
46 participants
Started: Oct 31, 2014 · Completed: May 31, 2019
Funding History (1)
D
Dec 29, 2017
Locations (1)
Headquarters
Maple Grove, MN, United States
Map
Loading map...